Virbac SA (EPA:VIRP)
354.50
+0.50 (0.14%)
Nov 3, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.97 billion as of November 3, 2026. It is the 4,717th most valuable company in the world and the 81st biggest in France. Its market cap has increased by 0.05% in one year.
Market Cap
2.97B
Enterprise Value
3.16B
Revenue
1.49B
Global Rank
Country Rank
#81 France
PE Ratio
19.08
ChartMarket Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.97B, an increase of 1,265.99%. That is a compound annual growth rate of 8.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 2.97B | -0.79% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 96.60B |
| EssilorLuxottica Société anonyme | 85.90B |
| Sartorius Stedim Biotech | 21.81B |
| Eurofins Scientific SE | 15.28B |
| ABIVAX Société Anonyme | 6.63B |
| emeis Société anonyme | 1.56B |
| Nanobiotix | 1.29B |
| Clariane SE | 1.12B |